Topchoice Medical Co., Inc. (SHA:600763)
China
· Delayed Price · Currency is CNY 47.09
+0.09 (0.19%)
Mar 10, 2026, 2:34 PM CST
Topchoice Medical Co. Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 21,023 | 19,860 | 24,513 | 49,055 | 63,807 | 88,663 | Upgrade
|
| Market Cap Growth | 6.33% | -18.98% | -50.03% | -23.12% | -28.03% | 169.70% | Upgrade
|
| Enterprise Value | 22,123 | 21,039 | 25,551 | 49,953 | 63,811 | 88,477 | Upgrade
|
| Last Close Price | 47.00 | 43.92 | 53.55 | 107.17 | 139.40 | 193.71 | Upgrade
|
| PE Ratio | 40.56 | 39.61 | 48.98 | 89.47 | 90.79 | 179.98 | Upgrade
|
| Forward PE | 41.62 | 46.14 | 29.21 | 76.15 | 75.61 | 129.07 | Upgrade
|
| PS Ratio | 7.17 | 6.91 | 8.61 | 18.04 | 22.95 | 42.47 | Upgrade
|
| PB Ratio | 4.47 | 4.56 | 5.93 | 13.56 | 20.29 | 37.76 | Upgrade
|
| P/TBV Ratio | 5.01 | 5.13 | 6.61 | 15.10 | 22.65 | 42.49 | Upgrade
|
| P/FCF Ratio | 39.82 | 46.05 | 73.81 | 197.39 | 111.53 | 164.80 | Upgrade
|
| P/OCF Ratio | 26.35 | 26.01 | 29.15 | 73.21 | 67.92 | 125.14 | Upgrade
|
| PEG Ratio | 4.50 | 2.28 | 2.28 | 2.28 | 2.28 | 2.28 | Upgrade
|
| EV/Sales Ratio | 7.55 | 7.32 | 8.98 | 18.37 | 22.95 | 42.38 | Upgrade
|
| EV/EBITDA Ratio | 24.64 | 27.00 | 32.78 | 61.17 | 63.76 | 124.09 | Upgrade
|
| EV/EBIT Ratio | 31.91 | 30.43 | 36.80 | 67.97 | 68.66 | 136.05 | Upgrade
|
| EV/FCF Ratio | 41.90 | 48.78 | 76.93 | 201.01 | 111.54 | 164.45 | Upgrade
|
| Debt / Equity Ratio | 0.28 | 0.33 | 0.35 | 0.32 | 0.41 | 0.10 | Upgrade
|
| Debt / EBITDA Ratio | 1.47 | 1.62 | 1.65 | 1.27 | 1.20 | 0.32 | Upgrade
|
| Debt / FCF Ratio | 2.50 | 3.35 | 4.39 | 4.64 | 2.27 | 0.42 | Upgrade
|
| Net Debt / Equity Ratio | 0.16 | 0.19 | 0.21 | 0.14 | 0.14 | -0.19 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.95 | 1.06 | 1.11 | 0.64 | 0.46 | -0.63 | Upgrade
|
| Net Debt / FCF Ratio | 1.40 | 1.91 | 2.60 | 2.11 | 0.80 | -0.83 | Upgrade
|
| Asset Turnover | 0.47 | 0.47 | 0.51 | 0.54 | 0.69 | 0.73 | Upgrade
|
| Inventory Turnover | 64.48 | 64.51 | 73.37 | 74.42 | 78.94 | 67.24 | Upgrade
|
| Quick Ratio | 1.47 | 1.55 | 1.15 | 1.67 | 1.56 | 1.69 | Upgrade
|
| Current Ratio | 1.62 | 1.68 | 1.40 | 2.33 | 1.63 | 1.82 | Upgrade
|
| Return on Equity (ROE) | 12.77% | 13.48% | 14.92% | 18.21% | 28.62% | 25.14% | Upgrade
|
| Return on Assets (ROA) | 6.93% | 7.06% | 7.74% | 9.09% | 14.49% | 14.13% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.60% | 11.20% | 12.40% | 15.84% | 27.26% | 27.59% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.10% | 12.30% | 12.90% | 15.70% | 21.50% | 25.00% | Upgrade
|
| Earnings Yield | 2.46% | 2.53% | 2.04% | 1.12% | 1.10% | 0.56% | Upgrade
|
| FCF Yield | 2.51% | 2.17% | 1.35% | 0.51% | 0.90% | 0.61% | Upgrade
|
| Dividend Yield | 0.94% | 1.03% | 0.58% | - | - | - | Upgrade
|
| Payout Ratio | 40.29% | 29.89% | 2.25% | 1.22% | 1.83% | 4.28% | Upgrade
|
| Buyback Yield / Dilution | 0.10% | -0.15% | 0.50% | 0.09% | -0.32% | 0.48% | Upgrade
|
| Total Shareholder Return | 1.05% | 0.88% | 1.08% | 0.09% | -0.32% | 0.48% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.